Crimean-Congo Hemorrhagic Fever: Prevention and Control Limitations in a Resource-Poor Country
Open Access
- 15 June 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (12) , 1731-1735
- https://doi.org/10.1086/421093
Abstract
In autumn 2000, an outbreak of Crimean-Congo hemorrhagic fever (CCHF) occurred in Pakistan and involved nosocomial cases due to human-to-human transmission at a tertiary care hospital in Karachi. During a hospital-based investigation, 6 serologically confirmed cases (i.e., patients seropositive for CCHF antigen or anti-CCHF immunoglobulin M antibodies by means of a capture enzyme-linked immunosorbent assay [ELISA]) and 3 clinically confirmed cases (i.e., patients with negative ELISA for CCHF but with relevant epidemiologic exposures and compatible clinical disease) of CCHF were identified. The outbreak originated in rural Balochistan, a region of known CCHF endemicity where miniepidemics regularly occur, and subsequently spread to the urban centers of Quetta and Karachi. This outbreak demonstrated the capacities and weaknesses associated with a developing country's response to hemorrhagic fever epidemics. We describe aspects of disease prevention, control challenges, and political obstacles posed by illness associated with what we refer to as the “Asian Ebola virus.”Keywords
This publication has 9 references indexed in Scilit:
- Risks to Health Care Workers in Developing CountriesNew England Journal of Medicine, 2001
- Risks and Prevention of Nosocomial Transmission of Rare Zoonotic DiseasesClinical Infectious Diseases, 2001
- Lessons from the West Nile Viral Encephalitis Outbreak in New York City, 1999: Implications for Bioterrorism PreparednessClinical Infectious Diseases, 2001
- Outbreak of Crimean‐Congo haemorrhagic fever in Quetta, Pakistan: contact tracing and risk assessmentTropical Medicine & International Health, 1998
- Crimean Congo-Haemorrhagic Fever treated with oral ribavirinThe Lancet, 1995
- Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal SyndromeThe Journal of Infectious Diseases, 1991
- Lassa FeverNew England Journal of Medicine, 1986
- Nosocomial Outbrak of Viral Hemorrhagic Fever Caused by Crimean Hemorrhagic Fever-Congo Virus in Pakistan, January 1976The American Journal of Tropical Medicine and Hygiene, 1980
- Review Article 1: The Epidemiology of Tick-Borne Crimean-Congo Hemorrhagic Fever in Asia, Europe, and Africa23Journal of Medical Entomology, 1979